- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02331056
Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?
October 6, 2016 updated by: Hyun Joo Ahn, Samsung Medical Center
There are some risks of pulmonary edema in patients undergoing pulmonary lobectomy with one lung ventilation.
The overloading of fluid administration could be related to the development of pulmonary edema in patents after thoracic surgery.
But fluid restriction may cause major organ hypoperfusion during the surgery.
The purpose of this study is to evaluate the ability of stroke volume variation as an indicator for a fluid responsiveness in patient who receives pulmonary lobectomy via thoracotomy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Perioperative fluid management during thoracic surgery is a significantly important, because it is quite difficult to prevent pulmonary edema due to the fluid overload and compromise perfusion of vital organ.
So, it is essential to maintain optimal organ perfusion by appropriate fluid management during thoracic surgery.
Stroke volume variation (SVV) is derived from pulse contour analysis and it is known that SVV ≥12~15% correlate with fluid responsiveness, defined as a significant increase in cardiac output with fluid loading, dung two-lung ventilation.
It is a parameter derived from changes in stroke volume (SV) that is according to the heart-lung interaction during mechanical ventilation.
positive pressure ventilation induces cyclic changes in left ventricular SV that are related mainly to the expiratory decrease in right ventricular filling and ejection.
This is a reflected by variations in the SV.
However both ventilator issues, such as tidal volume, PEEP, chest and lung condition, and the cardiovascular condition, such as heart rate, rhythm, ventricular function, cardiac afterload, arterial compliance may affect SVV.
Recently some studies reported that SVV could predict fluid responsiveness in mechanically ventilated patients under various conditions.
But it is still unclear whether SVV could predict fluid responsiveness during one lung ventilation with the chest open via a thoracotomy.
During one-lung ventilation, the shunted blood flow through the non-ventilated-lung dose not contribute to the generation of SVV.
And with the chest opening by thoracotomy, the pressure generated by ventilator would not be transmitted to the pulmonary vessels but rather to the atmosphere.
So, the purpose of this study is to evaluate the ability of SVV as an indicator a fluid responsiveness particularly in patients undergoing one-lung ventilation with thoracotomy and to found the optimal threshold value of SVV for fluid management during thoracic surgery.
Study Type
Observational
Enrollment (Actual)
79
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 135-710
- Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The patients scheduled for pulmonary lobectomy with one lung ventilation by lung cancer, nodule, or pulmonary tuberculosis under thoracoscopy or thoracotomy in our hospital were included.
Description
Inclusion Criteria:
- The patients scheduled for pulmonary lobectomy with one lung ventilation by lung cancer, nodule, or pulmonary tuberculosis under thoracoscopy or thoracotomy in our hospital
Exclusion Criteria:
- The patients with known cardiac disease include arrythmia
- American society of anesthesia physical status III, IV, V
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
thoracoscopic pulmonary lobectomy
to observe a fluid responsiveness in patients who receives scheduled thoracoscopic pulmonary lobectomy
|
Fluid loading at defined period
the patient group for scheduled thoracoscopic pulmonary lobectomy
|
|
open pulmonary lobectomy(thoracotomy)
to observe a fluid responsiveness in patients who receives scheduled open pulmonary lobectomy(thoracotomy)
|
Fluid loading at defined period
the patient group for scheduled open pulmonary lobectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes from baseline in SVV, SVI after fluid loading
Time Frame: 20min after thorax open and immediate after fluid loading for 30min
|
we are going to measure the SVV, SVI before and after fluid loading.
Fluid responders were defined as patients demonstrating an increase in SVI ≥ 10% and non-responders as patients whose SVI changed < 10%.
Receiver operating characteristic (ROC) curves were generated for SVV of each group (responders and non responders).
Threshold value of SVV was determined by considering values that yielded the greatest sensitivity and specificity from ROC curve
|
20min after thorax open and immediate after fluid loading for 30min
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants with Adverse Events (pulmonary complication)
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 week
|
after surgery check chest x-ray It's the routine follow up after lobectomy.
|
participants will be followed for the duration of hospital stay, an expected average of 1 week
|
|
Number of Participants with Adverse Events (compromise perfusion of vital organ )
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1 week
|
check perioperative urine output, and check post op serum creatine
|
participants will be followed for the duration of hospital stay, an expected average of 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hyun Joo Ahn, Samsung Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
December 15, 2014
First Submitted That Met QC Criteria
January 1, 2015
First Posted (Estimate)
January 5, 2015
Study Record Updates
Last Update Posted (Estimate)
October 7, 2016
Last Update Submitted That Met QC Criteria
October 6, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Neoplasms
- Lung Diseases
- Neoplasms by Site
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Bacterial Infections
- Bacterial Infections and Mycoses
- Gram-Positive Bacterial Infections
- Actinomycetales Infections
- Mycobacterium Infections
- Lung Neoplasms
- Tuberculosis
- Tuberculosis, Pulmonary
Other Study ID Numbers
- 2014-06-053-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Tuberculosis
-
Foundation for Innovative New Diagnostics, SwitzerlandInstitute of Tropical Medicine, Belgium; Research Center Borstel; National Institute...CompletedMultidrug-Resistant Tuberculosis | Isoniazid Resistant Pulmonary Tuberculosis | Rifampicin Resistant Tuberculosis | Pulmonary Tuberculoses
-
Huashan HospitalThe Hong Kong Polytechnic UniversityNot yet recruitingPulmonary Tuberculosis | Tuberculosis (TB) | Tuberculosis ActiveChina
-
Beijing Chest HospitalHuashan Hospital; National Medical Center for Infectious DiseasesNot yet recruitingTuberculosis | Drug-resistant Tuberculosis | Pulmonary Tuberculosis | Rifampicin Resistant TuberculosisChina
-
Universiteit AntwerpenAurum Institute; University of Stellenbosch; University of the Free State; Free...RecruitingDrug-resistant Tuberculosis | Rifampicin Resistant Tuberculosis | Pulmonary Tuberculoses | Multidrug Resistant TuberculosisSouth Africa
-
Shanghai Public Health Clinical CenterBeijing YouAn Hospital; Beijing Ditan Hospital; Peking Union Medical College... and other collaboratorsNot yet recruitingTuberculosis in HIV-infected Individuals | Drug Susceptible Pulmonary Tuberculosis
-
Tjip van der WerfGadjah Mada University; The Enose Company, Zutphen the NetherlandsCompletedPulmonary Tuberculosis Suspected | Other Specified Chronic Obstructive Pulmonary Disease | Pulmonary Tuberculosis TB (+) Histology, (-) BacteriologyIndonesia
-
Research Institute of Epidemiology, Microbiology...Active, not recruitingAspergillosis | Pulmonary Tuberculoses | Old Tuberculosis | Active Tuberculosis | Chronic Pulmonary AspergillosisUzbekistan
-
Sohag UniversityNot yet recruitingPulmonary and Extra- Pulmonary Tuberculosis (TB)Egypt
-
Gates Medical Research InstituteIQVIA RDS Inc.RecruitingDrug Susceptible Pulmonary TuberculosisSouth Africa
-
Medecins Sans Frontieres, NetherlandsLondon School of Hygiene and Tropical Medicine; University of Liverpool; Ministry... and other collaboratorsCompletedMulti-drug Resistant Tuberculosis | Pulmonary Tuberculoses | Extensively Drug-Resistant TuberculosisBelarus, South Africa, Uzbekistan
Clinical Trials on fluid loading
-
University of MilanUnknownCirculatory FailureItaly
-
Istanbul Saglik Bilimleri UniversityCompletedFluid Responsiveness | Intraoperative CareTurkey
-
Yonsei UniversityCompletedFluid Responsiveness PredictabilityKorea, Republic of
-
Samsung Medical CenterCompletedProne Position | Fluid Responsiveness | Non Invasive Cardiac Output MonitoringKorea, Republic of
-
Bursa City HospitalNot yet recruitingPediatric Surgery | Preoperative Fasting | Enhanced Recovery After Surgery (ERAS) ProtocolTurkey (Türkiye)
-
Seoul National University HospitalCompletedProstatic Neoplasm | Urinary Bladder NeoplasmKorea, Republic of
-
Samsung Medical CenterCompletedAbdominal Neoplasms | Gynecologic NeoplasmsKorea, Republic of
-
Seoul National University HospitalNot yet recruitingAnesthesia | Fluid Responsiveness
-
Samsung Medical CenterCompletedSternotomy | Cardiac Surgical Procedures | Thoracic Surgical ProceduresKorea, Republic of
-
Samsung Medical CenterCompletedKidney TransplantationKorea, Republic of